socalTECH

DECEMBER 17, 2020

which will trade ont he Nasdaq Capital Market as PALI. from Altium Capital, to fund continued development of the combined company's clinical programs. The newly merged company will focus specifically on advancing Leading Biosciences' lead pipeline asset, LB1148, in clinical studies. READ MORE>>.

Study 113

Study Capital Funding Marketing 113

socalTECH

MARCH 28, 2019

San Diego-based biotech startup Biolinq , which is developing wireless-enabled biosensor patches for continuous monitoring of biomarkers, has raised $4.75M additional Series A funding, the company said this morning. The funding came from JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners. Jared Tangney is CEO of Biolinq.

Marketing 168

Marketing San Diego Venture Capital Study 168

socalTECH

JULY 28, 2021

San Diego-based immunology startup Aristea Therapeutics says it has raised $63M in a Series B financing round, which was led by Fidelity Management & Research Company, LLC, along with Novo Holdings A/S, plus Arena Pharmaceuticals and funds managed by Tekla Capital Management, LLC.

San Diego 100

San Diego Study Research Capital 100

Xconomy

DECEMBER 20, 2018

New biopharma company Aristea Therapeutics has raised $15 million from Novo Holdings, the Danish investment company, and secured global rights to an investigational AstraZeneca drug that’s ready for Phase 2 study. The San Diego, CA, company made its public debut this week after starting up quietly earlier this year.

Develop 67

Develop Development San Diego Study 67

socalTECH

JANUARY 10, 2023

San Diego-based CARI Health, which is developing a wearable, real-time mediation monitor, said on Tuesday that it has raised $2.3M The company said the funding will go towards in-patient clinical studies. The company said the funding will go towards in-patient clinical studies. in a seed funding round.

San Diego 133

San Diego Seed Funding Study Conference 133

socalTECH

MAY 4, 2018

Playa Vista-based Science 37 , the venture backed startup which is developing technology to allow pharmaceutical companies to conduct clinical trials at patients' homes, has linked with pharmaceuticals firm UBC. Financial details of the deal were not announced. READ MORE>>.

Study 113

Study Google Capital Invest 113

socalTECH

AUGUST 31, 2021

San Diego-based "ARS Pharmaceuticals, which is developing an epinephrine nasal spray designed to better treat severe allergic reaction, said today that it has raised $55M in a Series D funding. The funding was led by SR One, and also included RA Capital Management, an un-named US healthcare-focused fund, and Deerfield Management.

Funding 113

Funding San Diego Study Design 113

socalTECH

APRIL 28, 2017

According to Epic Sciences, the funding was led by Hermed Capital, and also included Altos Capital Partners, Domain Associates, Genomic Health, Pagoda Investment, Reach Tone Limited, RMI Partners, Sabby Capital and VI Ventures. Epic sciences is developing blood-based tests which help predict drug response in cancer.

Funding 153

Funding San Diego Study Capital 153

socalTECH

MAY 2, 2017

Irvine-based Axonics , a developer of medical devices to treat urinary and fecal dysfunction, has raised $14.5M The company said the funding will go towards a clinical study in overactive bladder patients, to gain U.S. Axonics said it hopes to begin that study in the second half of the year. FDA approval. READ MORE>>.

Study 138

Study Funding Capital Invest 138

socalTECH

NOVEMBER 7, 2018

San Diego-based Mirium Pharmaceuticals , which is developing treatments for rare liver diseases, announced on Wednesday morning that it has raised $120M in a Series A funding round. The company says it recently had a successful Phase 2b study. READ MORE>>.

San Diego 147

San Diego Study Capital Funding 147

Startup Professionals Musings

APRIL 13, 2015

Yet I still get too many business plans that clearly are looking for money to do research and development (R&D) on a new and unproven technology. Applied research is still primarily scientific study, seeking to solve practical problems, but doesn’t yet focus on a commercial product. Commercial product prototypes.

Develop 102

Develop Development Product Funding 102

socalTECH

NOVEMBER 9, 2020

San Diego-based Arcturus Therapeutics has received up to $220M in additional financial commitments from the country of Singapore, after receiving positive Phase 1/2 study results on one of its compounds.

Arcturus 113

Arcturus Study San Diego Funding 113

socalTECH

OCTOBER 1, 2018

San Diego-based VelosBio , a biotech startup developing novel antibody-drug conjugates to treat hematological cancers and solid tumours, has raised $58M in a funding round. The Series A funding was led by Arix Bioscience, and also included Pappas Ventures, Chiesi Ventures, Takeda Ventures, and Decheng Capital. READ MORE>>.

San Diego 113

San Diego Study Funding Capital 113

Both Sides of the Table

APRIL 21, 2010

Investors: Foundation Capital (lead), with existing investors: Morgenthaler Ventures, Norwest Venture Partners, Canaan Partners. Studying for the SAT, LSAT, GMAT, TOEFL, MCAT and other standardized tests in the US is a massive market that has been dominated for years by Kaplan and Princeton Review. Online peer-to-peer lending.

Venture Capital 265

Venture Capital Capital Email Blogging 265

socalTECH

NOVEMBER 22, 2021

San Diego-based medical visualization software developer LifeVoxel.AI LifeVoxel said it offers up aces to imaging studies and data, allowing for what it calls "4D interactive intelligent medical image views" over the Internet. announced this morning that it has raised $5M in a seed funding round.

Seed Funding 140

Seed Funding San Diego Study Software Development 140

TechCrunch LA

MARCH 11, 2021

It is complexity theory made manifest and only serves to show that scalable, data-driven solutions rapidly deployed across large industrial markets are our only hope in correcting the course,” wrote Vaughn Blake, a partner at the energy-focused investment firm Blue Bear Capital. Intel alone used 9 billion gallons of water in 2015).

Artificial Inteligence 162

Artificial Inteligence Case Study Study Los Angeles 162

socalTECH

DECEMBER 5, 2018

FactoryFour , a startup which developing software to enable custom production of industrial goods, has raised $5M in a Series A funding, and set up shop in Culver City. The startup's Series A funding was led by August Capital, and also included existing investor Refactor Capital.

Culver City 113

Culver City Startup Study Los Angeles 113

socalTECH

FEBRUARY 22, 2018

Santa Monica-based cloud-based learning and human capital management software developer Cornerstone OnDemand is aiming to make it easier for employers to help their people learn the skills they need to survive in the "workplace of tomorrow", through a link with think tank Institute for the Future. READ MORE>>.

Cornerstone OnDemand 113

Cornerstone OnDemand Santa Monica Study Software Development 113

socalTECH

MAY 25, 2016

Santa Monica-based March Capital Partners (www.marchcp.com) has just announced a brand new, $240M venture investment fund, led by longtime venture investing veterans Jim Armstrong, Sumant Mandal, Gregory Milken and Jamie Montgomery. That network effect is a subtle but has a powerful effect with all this new technology. Big ideas rule the day.

Southern California 113

Southern California Capital Funding Invest 113

Startup Professionals Musings

JULY 1, 2017

According to my experience and a classic Gompers and Lerner study, the challenge is very real, with a majority of new ventures that don't attract investors failing within the first three years. Software apps that once required a 10-person team can now be done with the Lean Development methodology by two people in a couple of months.

Develop 70

Develop Development Product Startup 70

socalTECH

JANUARY 24, 2019

Irvine-based Modulated Imaging , a developer of optical imaging products used for noninvasive assessment of tissue health, has raised $7M in a Series B funding, according to the company. The new funding was led by Pangaea Ventures and also included Fresenius Medical Care Ventures GmbH, Grey Sky Venture Partners, Mitsubishi UFJ Capital Co.

Study 113

Study Funding Product Capital 113

socalTECH

MARCH 28, 2018

La Jolla-based Singlera Genomics , which is developing genetic diagnostics for early stage cancer detection, has raised $60M in a Series A+ funding round, according to the company. The company said it is focusing on early stage detection of cancer using cell-free DNA. The company's initial target is early detection of lung cancer.

Study 100

Study Research Funding Capital 100

socalTECH

JANUARY 5, 2016

San Diego-based Halozyme Therapeutics , the publicly held cancer therapeutics developer, has entered into a $150M credit agreement, the company said this morning. The debt funding comes from Pharmakon Advisors and Athyrium Capital Management. READ MORE>>.

Study 100

Study San Diego Capital Funding 100

Both Sides of the Table

FEBRUARY 12, 2019

Over the past month a colleague ( Chang Xu ) and I sifted through data on the venture capital industry (as we do every year) and made a bunch of calls to VCs and LPs to confirm our hypotheses. As a result of the IPO window shifting we saw a massive inflow of public-market capital into the latest stages of venture. What gives?

Venture Capital 328

Venture Capital Invest Seed Funding Startup 328

Startup Professionals Musings

OCTOBER 2, 2023

Yet I still get too many business plans that clearly are looking for money to do research and development (R&D) on a new and unproven technology. Applied research is still primarily scientific study, seeking to solve practical problems, but doesn’t yet focus on a commercial product. Commercial product prototypes.

Resource 102

Resource Ideas Funding Research 102

socalTECH

JUNE 24, 2019

AFYX Therapeutics is developing treatments for mucosal diseases, with its lead compound aimed at treatment of oral lichen planus. The company is currently in an ongoing, Phase 2B study. The note came from Sofinnova Ventuers, which led the investment, and also included Nova Seeds and Lundbeckfonden Emerge.

Study 113

Study San Diego Platform Invest 113

socalTECH

MAY 18, 2021

Los Angeles-based Narrativa, a developer of artificial intelligence software aimed at helping pharmaceutical companies with FDA drug approvals, says it has raised $1.3M According to Narrativa, it is using its AI software to automate the generation of Clinical Study Reports (CSRs) and other regulatory reports. in a financing round.

Artificial Inteligence 113

Artificial Inteligence Study Report Los Angeles 113

socalTECH

JUNE 6, 2018

Santa Monica-based Headspace , which develops mindfulness and meditation apps, says it is targeting the medical market with the launch of a new, digital medicine subsidiary it calls "Headspace Health". Headspace says its apps have been used in more than 65 evidence-based research studies, run by U.K.'s

Marketing 100

Marketing Southern California Santa Monica Study 100

socalTECH

APRIL 8, 2014

Aliso Viejo-based Sequent Medical , which is developing medical devices for treating aneurysms, said Tuesday that it has raised $20M in a Series D funding. Sequent said the funds will go towards its US clinical studies and to broaden its product portfolio. sequent medical aneurysm device venture capital lifescience surgery'

Venture Capital 147

Venture Capital Study Funding Capital 147

socalTECH

AUGUST 17, 2020

Tustin, California-based THREAD , a developer of software used for managing decentralized clinical research, has raised $50 more in funding from private equity investors Water Street Healthare Partners and JLL Partners. The company was acquired by Water Street and JLL Partners last year, in 2019. THREAD's executive chairman is Mark A.

Outsource Development 113

Outsource Development Research Study Equity 113

Startup Professionals Musings

APRIL 30, 2023

Risk level has always been directly correlated to the number of unknowns, so eliminating even one variable will improve your odds: Eliminate one aspect of research and development. According to a classic Harvard Research study, first inventors spend at least a third more on their initial technology than later innovators.

Social Media 92

Social Media Study Research Satisfaction 92

socalTECH

AUGUST 14, 2014

AuditFile , a developer of cloud-based auditing software for CPAs, has raised $3M in a funding round, the company said Thursday. Kevin--now COO--studied computer science and accounting at UCLA. auditfile venture capital cloud software auditing accounting saas ucla dorm room student' READ MORE>>.

UCLA 170

UCLA Draper Software SaaS 170

socalTECH

SEPTEMBER 12, 2018

San Diego-based Epic Sciences , which is developing technology around personalization of cancer treatment and management, has raised $52M more in a Series E funding, the company's lead investor said this morning. Epic has now raised more than $137.5M RUSNANO, and VI Ventures. READ MORE>>.

Artificial Inteligence 100

Artificial Inteligence San Diego Study Invest 100

socalTECH

JUNE 4, 2015

Pasadena-based Calhoun Vision , a company which is developing implantable, light adjusting intraocular lenses used to treat cataract surgery, has raised $69.0M The financing was led by Longitude Capital, and also included H.I.G. BioVentures, Balance Point Capital Partners, and RA Capital Management.

Pasadena 100

Pasadena Study Equity Capital 100

socalTECH

JANUARY 27, 2016

San Diego-based biopharmaceuticals developer Halozyme Therapeutics said yesterday that it has raised $150M in royalty-backed, debt financing. The financing came from Pharmakon Advisors and Athyrium Capital Management. According to the company, the funding will go towards a Phase 3 cancer study in cancer patients.

Funding 100

Funding San Diego Study Capital 100

Both Sides of the Table

SEPTEMBER 15, 2022

At our mid-year offsite our partnership at Upfront Ventures was discussing what the future of venture capital and the startup ecosystem looked like. No blog post about how Tiger is crushing everybody because it’s deploying all its capital in 1-year while “suckers” are investing over 3-years can change this reality.

Venture Capital 416

Venture Capital Marketing Technical Review Seed Funding 416

Xconomy

JUNE 19, 2019

Cancer immunotherapies have shown to be effective as a treatment for some cancers, but only in a fraction of patients. Oncolytics, which. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Study 61

Study Activity Develop Development 61